newsfilter
← Latest News
FDA Approved Drugs·

Approval of Aplenzin, Nda #022108 (Labeling)

Approval Date: 11/05/2025; Drug Name: Aplenzin, Nda #022108; Active Ingredients: BUPROPION HYDROBROMIDE; Company: Bausch; Submission Status: Approval; Submission Classification: Labeling; Application Number: 022108

Company
BAUSCH
Keywords
BAUSCH